01 5Brovana
Main Therapeutic Indication : Respiratory Disorders
Currency : USD
2020 Revenue in Millions : 299
2019 Revenue in Millions : 332
Growth (%) : -10
Main Therapeutic Indication : Respiratory Disorders
Currency : USD
2021 Revenue in Millions : 153
2020 Revenue in Millions : 299
Growth (%) : -42
Main Therapeutic Indication : Respiratory Diseases
Currency : USD
2022 Revenue in Millions : 45
2021 Revenue in Millions : 153
Growth (%) : -71
Main Therapeutic Indication : Respiratory Diseases
Currency : USD
2023 Revenue in Millions : 0
2022 Revenue in Millions : 45
Growth (%) : -100
Main Therapeutic Indication : Respiratory Disorders
Currency : USD
2019 Revenue in Millions : 320
2018 Revenue in Millions : 308
Growth (%) : 4
